# Critique Phase 4 epic-emulator problem statement

## Turn 1

### Prompt

I want to implement a Phase 4 now. Planning and brainstorming comes first, so do not implement or write anything yet. Do not yet architect anything, think about writing a PRD in subsequent prompts, not right now.

First, critique this problem statement:

__________________

Problem Statement — epic-emulator (Phase 4)

Context. fhir-service is intentionally EHR-agnostic. Per its roadmap, epic-emulator is the still-unbuilt module meant to simulate Epic-specific integration behavior — Epic's authentication flows, custom FHIR extensions/profiles, and proprietary API quirks — so the rest of the platform can be developed and tested against realistic Epic-like behavior without a real Epic sandbox.

Why monolith-first, specifically (the engineering rationale). The domain boundaries within Epic emulation are not yet known. Auth flow, custom extension handling, and proprietary-quirk simulation might turn out to be cleanly separable — or they might turn out to share more state and logic than expected (e.g., auth context needed by extension validation, shared request/response shaping across "quirks"). Committing to service boundaries now, before writing any real code against them, risks locking in an incorrect cut that becomes expensive to undo across separate repos, deploy pipelines, and network contracts. Per Fowler's MonolithFirst pattern, the correct sequence is: build it together, let real usage reveal where the actual seams are, then decompose along boundaries that are now evidence-based rather than guessed.

The problem to solve in Phase 4. Build a working, end-to-end epic-emulator as one deployable Spring Boot application, one Maven build, optimized for speed to a working prototype. Concretely, Phase 4 is scoped to skip every piece of work that would only be justified once real service boundaries exist:

Skipped in Phase 4 (deferred to Phase 5)	Why it's safe to skip now
Separate repos/builds per capability area	No confirmed boundary to split along yet
Per-area Dockerfiles / container images	One process to run and iterate on locally
K8s manifests, Kong routes per area	No independent deployability claim being made yet
Inter-area REST contracts / DTOs / serialization	No network boundary exists yet — direct method calls are correct, not sloppy
Per-area CI pipelines, integration tests across a network boundary	Nothing to integration-test across yet

This list is the speed argument — each row is real time and complexity a microservices-first approach would have paid upfront, before knowing if the boundary was even right.

Candidate capability areas (hypotheses to validate during Phase 4 — not commitments; Phase 5's actual decomposition should follow what real coupling patterns show up, not this list):

Epic auth emulation — SMART-on-FHIR / backend-services OAuth2 flow simulation.
Epic custom profile & extension handling — validating/injecting Epic-specific FHIR extensions on top of fhir-service's base R4 resources.
Epic proprietary quirks — non-standard pagination, search params, error shapes.


Explicit non-goals for Phase 4. Independent deployability, internal API boundaries between areas, containerization beyond a single local-run Dockerfile, production hardening. These aren't omissions — they're costs correctly deferred until Phase 5 has evidence to spend them well.

Constraints. Java 21, Spring Boot, Maven — same toolchain already proven in fhir-service, so none of Phase 5's later containerization/K8s/Kong work is new territory, only newly justified.

Success criteria for Phase 4.

All three candidate capability areas demonstrably working end-to-end, in one running process.
Zero artifacts from the "skipped" table above exist in the repo at the end of Phase 4 — this is the concrete, checkable evidence for the speed claim.

A short written note (a few sentences, captured for Phase 5) on which capability areas turned out to share state/logic in practice, and which stayed cleanly separate — this is the real output that makes Phase 5's decomposition evidence-based rather than a repeat of the original guess. This should be done with actual testing, mimicking business and clinical stakeholders assessments.

Forward note for Phase 5. Decomposition boundaries should be derived from what Phase 4 actually revealed about coupling and change patterns — not from the candidate list above verbatim. If two "areas" turned out to share significant state, that's a signal they may belong in the same service even after decomposition; that's the MonolithFirst payoff, and it's the part of this exercise that makes the whole Phase 4 → Phase 5 story a legitimate engineering decision rather than a staged one.

### Claude response

Solid structure overall — the skip-table-with-rationale and the "zero artifacts" check are good instincts. But there are real gaps, ranked by how much they matter:

**1. The document justifies the easy decision and skips the hard one.**
Most of the word count defends "don't split into 3 microservices yet." But nobody was seriously proposing that — three tightly-coupled sub-features of one emulator becoming three separate repos/deploys was never a live option worth this much argument. Citing Fowler's MonolithFirst (which is about whether a *new product* starts as microservices) to justify not over-decomposing a single module is solving a strawman. The actual hard question — **what does "correctly emulating Epic" even mean, and how do you know you got it right without a real Epic sandbox** — gets zero words. That's the riskier unknown and belongs in the problem statement, not the module-boundary question.

**2. "Demonstrably working end-to-end" has no source of truth.**
Working against what reference? Epic's published FHIR API docs / SMART Backend Services spec / App Orchard sandbox behavior? Without naming an authority to emulate against, "working" is whatever the implementer assumed, and Phase 5 (or a real Epic integration later) could discover the emulation was subtly wrong in ways the success criteria never would have caught.

**3. "Proprietary quirks" is unbounded scope, not a capability.**
Auth flow and custom extensions are concrete. "Quirks" (pagination, search params, error shapes) is an open-ended grab-bag that could expand indefinitely — which directly undermines the stated "optimized for speed" goal. This needs a specific, enumerated, closed list for Phase 4, or it'll be the thing that blows the timebox.

**4. No integration story.**
Who actually calls epic-emulator, and how does a developer switch between it and real fhir-service? Does it sit in front of fhir-service as a proxy, wrap it, or run standalone with its own store? Given the existing convention that `client/clinical` and `client/platform` serve different audiences, which one talks to epic-emulator matters and isn't addressed.

**5. The MonolithFirst argument is weaker here than in its original context.**
Fowler's pattern relies on *real production usage* revealing seams. Here the "usage" will be internal test suites exercising three areas together — which is fine, but it should be stated explicitly as the mechanism, and the success criteria should require enough test depth that the coupling findings in Phase 4's closing note are actually trustworthy, not superficial.

**6. "Zero artifacts from the skip table" is necessary but gameable.**
It's an absence check, not a correctness check. You could satisfy it letter-for-letter while still building internal package boundaries with DTO-style interfaces and strict method contracts between "areas" — i.e., paying microservice-shaped costs without any of the artifacts. Worth a note that the spirit (not just deployment artifacts) is being checked.

**7. Success criterion #3's stakeholder-testing sentence is out of place.**
"This should be done with actual testing, mimicking business and clinical stakeholder assessments" — for what is fundamentally a technical integration/auth/protocol emulator, it's unclear what a clinical stakeholder is assessing. Either this means "get a demo sign-off" or it's conflating two different kinds of validation. Needs disambiguation before it goes in a PRD.

**8. Security sensitivity of the auth-emulation piece is unflagged.**
Per this repo's own rules, security-sensitive code gets deeper scrutiny regardless of "it's just a prototype." Emulating OAuth2/SMART-on-FHIR backend-services flow means fake tokens/keys/signing — worth an explicit callout so shortcuts here don't later get mistaken for validated patterns elsewhere.

**Smaller open questions worth resolving before a PRD:**
- Where does epic-emulator physically live — new top-level dir, or a module under `fhir-service/`? Affects Maven setup and the repo table in CLAUDE.md.
- Data/fixtures: reuse `data/scripts/` Synthea generation, or does Epic-flavored data need its own fixtures?
- No timebox or rough size estimate for Phase 4 — "speed to prototype" isn't falsifiable without one.

Want me to hold these for when you actually draft the PRD, or react to any of them now?

## Turn 2

### Prompt

I want you to build a monolith first. Justify that using your best judgement - answer your own questions by modifying and changing, if necessary, the problem statement itself. Fill in the gaps, maybe give me options to choose from. I want to build a monolith real fast without consulting business and clinical stakeholders too much. Or tell me hos else to justify this.

### Claude response

Good — I'll fold my own critique points back into the statement, make judgment calls where I have enough to go on, and flag the two spots where I genuinely need your call rather than guessing. I'm keeping this at problem-statement altitude — no code, no class diagrams.

## Revised Problem Statement — epic-emulator (Phase 4)

**Context.** Unchanged: `fhir-service` is EHR-agnostic; `epic-emulator` simulates Epic-specific behavior on top of it so the rest of the platform can be built/tested without a real Epic sandbox.

**Monolith-first, compressed.** Auth, extension-handling, and quirk-simulation are three sub-features of one small module, not three products — splitting them into separate deployables was never a real option worth defending at length. The one-paragraph version: boundaries aren't known yet, so use direct method calls internally, and let Phase 4's own build reveal whether any of the three areas turn out to share more state than expected. Fowler's MonolithFirst gets one sentence, not a page.

**The actual hard problem, now named explicitly: what counts as "correct" Epic-like behavior without a real Epic sandbox?**
Answer: treat Epic's own public documentation as the source of truth, not an internal guess —
- **Auth** → the SMART App Launch "Backend Services" (client-credentials-style, JWT-assertion) authorization flow, which is publicly specified and is what Epic's backend systems documentation implements.
- **Extensions** → don't emulate "any Epic extension" (unbounded). Scope to extensions relevant to this repo's existing reference workflow — medication and allergy/intolerance resources — since that's the one clinical scenario already wired end-to-end (`triage-service/src/triage/rules.py`).
- **Quirks** → bounded to exactly three, not an open list: (1) non-standard pagination/`_count` behavior, (2) a documented non-standard search-parameter requirement (e.g., required parameter combinations Epic enforces that base R4 doesn't), (3) Epic's `OperationOutcome` error-shape deviations. If a fourth quirk is discovered mid-build, it goes on a Phase 5 backlog, not into Phase 4 scope.

This makes "demonstrably working" checkable: **it means spec-conformant to those named public sources**, not "looks plausible."

**Integration architecture — real choice, not guessed.** Two viable shapes; recommending the first:

1. **(Recommended) Standalone Spring Boot app, own embedded HAPI FHIR JPA store** (same stack `fhir-service` already uses), with Epic-specific auth filter + extension StructureDefinitions/validators + custom interceptors for the three quirks layered on top via HAPI's native interceptor mechanism. Point the existing `data/scripts/` Synthea seeding at its port for fixtures. Fastest to build — no proxy/rewrite layer needed, and doesn't require `fhir-service` to be running to test it.
2. **Proxy in front of `fhir-service`**: forwards CRUD to the real service, layers Epic auth/extensions/quirks as request/response transforms. More "realistic" (single source of truth for data, no duplicate fixtures) but requires designing a transform pipeline and running two processes for any test.

**Clarifying the skip-table scope:** the "no inter-service network calls" rule applies to auth/extensions/quirks talking to *each other* — those stay direct method calls in-process. It does **not** forbid epic-emulator from calling `fhir-service` over HTTP if you pick option 2 above — that's an existing, already-established service boundary from the current architecture, not a new one being guessed at.

**Success criteria, revised:**
1. All three areas working end-to-end against the named public specs (auth flow completes per SMART Backend Services; the medication/allergy extensions validate/inject correctly; all three named quirks reproduce).
2. Zero artifacts from the skip table — **plus** no internal package-level interfaces/DTOs that mimic a future REST boundary between the three areas. Direct calls and shared classes only.
3. **Replacing the stakeholder-assessment line** (dropped per your ask to minimize business/clinical consultation): the acceptance test is running the *existing* prescription-refill-risk-triage scenario through `mcp-agent`/`triage-service` pointed at epic-emulator instead of `fhir-service`, and confirming it produces the same clinical answer. That's self-directed, uses infrastructure you already have, and needs no outside sign-off.
4. A short written note on observed coupling (kept as-is — this is the real Phase 5 input).

**Security note, added:** the auth emulation must be unmistakably test-only — dummy keys/certs, no real secret material, and some visible marker (config flag, log banner) that prevents it from ever being mistaken for a production credential path.

**Sizing:** scoped so a single engineer could plausibly finish it in days, not weeks — the three-quirk cap and reference-workflow-scoped extensions above are chosen with that ceiling in mind, not just to sound minimal.

Two things I made a judgment call on but you may want to override:

Got it — proxy-in-front-of-fhir-service, new top-level `epic-emulator/` directory. Updating the problem statement accordingly:

- **Integration architecture:** epic-emulator is a proxy/gateway layer in front of `fhir-service`. It forwards standard CRUD to the real service and layers Epic auth (SMART Backend Services), the medication/allergy extension handling, and the three named quirks as request/response transforms. Single source of truth for FHIR data — no duplicate fixtures, reuses whatever `fhir-service` already has seeded.
- **Consequence worth flagging now:** testing epic-emulator requires both processes running (epic-emulator + fhir-service), unlike the standalone option. Worth deciding later whether local dev/CI spins up both automatically or whether that's left manual for Phase 4.
- **Repo location:** `epic-emulator/` as a new top-level directory, own Maven build/pom — same pattern as `fhir-service/`, `triage-service/`, `mcp-agent/` in the existing layout table. It'll depend on `fhir-service` only at runtime (HTTP calls), not as a build dependency.

That resolves the two open architecture-adjacent questions. The problem statement is otherwise as revised above: source-of-truth specs named (SMART Backend Services, medication/allergy-scoped extensions, 3 bounded quirks), stakeholder-assessment criterion replaced with the self-directed prescription-refill-triage acceptance test, security callout on fake-only credentials, and the tightened zero-artifact/no-internal-DTO check.

Say the word when you want to move to drafting the actual PRD.

## Turn 3

### Prompt

(1) Tell me the 3 parts, components, or use cases (choose the correct terminology) again. (2) What is the most realistic info/documentation/sandbox for free use that we can get easily from Epic?

### Claude response

**1) The three parts — correct terminology.**
The problem statement calls them **"candidate capability areas"** (deliberately not "services" or "components," to avoid implying a decomposition commitment before Phase 5 has evidence). Functionally, each is also a working end-to-end use case inside the monolith:

1. **Epic auth emulation** — SMART App Launch "Backend Services" OAuth2 flow (client-credentials-style, JWT client assertion).
2. **Epic custom profile & extension handling** — scoped to extensions on Medication/AllergyIntolerance resources (tied to the existing prescription-refill-risk-triage reference workflow, not "any Epic extension").
3. **Epic proprietary quirks** — bounded to exactly three: non-standard pagination/`_count` behavior, a non-standard required search-parameter combination, and `OperationOutcome` error-shape deviations.

**2) Most realistic free Epic docs/sandbox.**
**Epic on FHIR** (`fhir.epic.com`) is the real, publicly-known developer resource for this — it's Epic's own vendor developer portal and doesn't require being a hospital/Epic customer:

- **Free self-service developer account** — anyone can register (no affiliation with an Epic-using health system needed) and get access to a shared **non-production sandbox tenant** with synthetic test patients, usable for both SMART app-launch and backend-services (JWT) OAuth2 flows. This is the closest thing to "real Epic behavior" available without a hospital's actual instance.
- **Per-resource API documentation** — pages for each FHIR resource (Patient, MedicationRequest, AllergyIntolerance, etc.) listing exactly which search parameters Epic supports/partially-supports, and which Epic-specific extensions it adds on top of base R4. This is the direct source for scoping capability area #2 concretely instead of guessing.
- **A written guide for the backend-services JWT auth flow** — this is the spec-level reference for capability area #1, independent of having live sandbox access.

Caveat: Epic's documented FHIR support (search params, extensions) varies by the client's Epic software version, and the docs are versioned accordingly — worth picking one Epic version's documentation set as the fixed reference for Phase 4 rather than mixing across versions. I'd treat the sandbox as useful for auth-flow shape and response examples, and the per-resource doc pages as the primary source of truth for extensions/quirks, since sandbox data is synthetic and won't necessarily exercise every quirk you need.

## Turn 4

### Prompt

What have I done related to Pharmacy Benefits Management that I can include/repurpose/expand for this phase?

### Claude response

Phase 2 (claims-adjudication modernization) is exactly Pharmacy Benefits Management work, even though it's not labeled that way — and it hands you a working precedent for almost the exact shape of problem Phase 4 is solving. Here's what's directly usable:

**1. `rxclaim-emulator/` — the architectural template, not just prior art.**
[rxclaim-emulator/README.md](rxclaim-emulator/README.md) is a Spring Boot service that simulates a real proprietary legacy system (IBM i / RxClaim: fixed-width DDS records, DB2-style tables, its own quirky wire format) sitting behind an internal-only REST façade, with the "real" system-of-record data and an anti-corruption layer in front of it. That is structurally the same problem as epic-emulator: **simulate a real vendor's non-standard contract on top of standard data, internal-only, own H2 store, own Spring Boot module.** Repurposable directly:
- The module layout itself (`legacy/` fixed-record classes, `core/` deterministic engine, thin REST controller, H2 via `schema.sql`) — same pattern for Epic's quirky request/response shapes.
- The Dockerfile + `infra/main.tf` Cloud Run stub with `ingress=INTERNAL_ONLY` — literally reusable as the Phase 5 cloud-stub template for epic-emulator.
- The test-pinning trick for the ambient `SPRING_DATASOURCE_URL`/`NEON_*` env-var gotcha (same issue CLAUDE.md already flags for `fhir-service`).

**2. `claims-service`'s anti-corruption layer (`acl/LegacyAdapter`) — the exact pattern for Epic's quirk-translation layer.**
[claims-service/README.md](claims-service/README.md) shows a proven, tested pattern for "translate between a modern canonical shape and a proprietary wire format, and make that translation the one class that knows the legacy format." That's precisely what epic-emulator's proxy layer needs to do between `fhir-service`'s base R4 and Epic's extensions/pagination/error-shape quirks — same seam, same discipline (one adapter class owns the wire-format knowledge, everything else stays canonical).

**3. `data/payer-kb/` — real, grounded medication/formulary data you can repurpose as test fixtures.**
[data/payer-kb/README.md](data/payer-kb/README.md) already has real CMS Part D + ACA QHP-grounded formulary data, an NDC↔RxCUI crosswalk, and named drug scenarios (lisinopril, semaglutide, amoxicillin + penicillin allergy). Since Phase 4's extension scope is now scoped to Medication/AllergyIntolerance resources, this is a ready-made source of realistic drug/allergy test data — no need to invent fixtures from scratch; point Synthea/seed data at drugs already grounded here.

**4. Engineering patterns worth carrying over, not just code:**
- **Fail-closed on an unavailable check** (R17.5 in claims-service: unknown ≠ safe, defaults to the conservative outcome) — directly applicable if Epic auth or extension validation can't complete; don't silently treat "couldn't validate" as "valid."
- **Phase-independence CI gate** — Phase 2 added a CI job proving Phase 1 still passes without Phase 2 present ([phase2-planning-state.md] M7). Phase 4 should do the same: prove existing services still run/test independently of epic-emulator.
- **Separate agent, not an extension of mcp-agent** — Phase 2 deliberately kept `claims-agent` standalone rather than bolting onto `mcp-agent`. Worth the same instinct if epic-emulator ever needs its own orchestration/test client.

**What doesn't transfer:** the claims-service rules engine itself (eligibility/PA/formulary decisioning) is genuinely PBM business logic — not relevant to Epic emulation, which is a protocol/format concern, not a clinical-decision concern. Don't reach for that part.

Want me to fold the "rxclaim-emulator as the direct architectural template" point into the problem statement now, or hold it for the PRD?

## Turn 5

### Prompt

I am thnking of bundling the risk triage service and claims adjududicatiron functionality of epic emulation into one monolith, maybe in addition to the three candidate capability areas you mentioned. Does that make sense?

### Claude response

Short answer: bundling the auth/extension/quirk work into one monolith made sense because those three are unknown, unbuilt, and share a genuinely uncertain boundary. Triage-service and claims-service are the opposite case — they're already-built, already-decomposed, already-validated services with a boundary that's been deliberately tested, not guessed. Pulling their logic into epic-emulator isn't monolith-first, it's un-deciding a decision you already made and validated.

**Three concrete reasons this cuts against your own goals, not just mine:**

1. **You already locked "Phase 1 stays independently runnable/testable/deployable"** as a hard constraint in Phase 2 planning, and Phase 2 explicitly *reused* triage-service over HTTP rather than rebuilding its logic ("REUSE Python triage `POST /triage/refill-risk`... no rebuild" — a locked framing decision). Embedding triage/claims logic in epic-emulator creates a second copy of clinical/claims decisioning, which is exactly the kind of duplication that decision was designed to prevent.
2. **CLAUDE.md already draws this line on purpose**: "the agent orchestrates but holds no clinical logic (rules live in `triage-service/src/triage/rules.py`)." Epic-emulator's job is to look like Epic from the outside — a protocol/format concern. Clinical risk and claims adjudication are business-logic concerns. Merging them muddies which service is authoritative for a clinical decision, which is precisely the kind of change CLAUDE.md flags for deeper scrutiny (healthcare compliance / data integrity), not a speed shortcut.
3. **It roughly triples Phase 4's scope**, working directly against the "build fast, days not weeks" sizing you asked for a few turns ago. Two already-built services' worth of logic is a much bigger lift than three unbuilt sub-features of one new module.

**What I suspect you actually want, and which does make sense:** exercise triage-service and claims-service *through* epic-emulator, not absorb their code into it. That's already consistent with the architecture you picked — epic-emulator is a proxy in front of `fhir-service`, and triage-service/claims-service already read/write against `fhir-service`. So an Epic-flavored end-to-end demo (mcp-agent or claims-agent → epic-emulator's Epic auth/extensions/quirks → fhir-service, with triage-service and claims-service in their normal place in the chain) gives you a realistic, fuller demo without duplicating a single rule. This also strengthens the acceptance test I proposed earlier — instead of just the refill-triage scenario, you could run *both* the triage scenario and a claims-adjudication scenario through epic-emulator as the acceptance bar.

Want me to fold that "call, don't absorb" framing into the problem statement instead of the bundling version?

## Turn 6

### Prompt

Just use the following 3 "candidate capability areas" as you mentioned before:

1. Epic auth emulation — SMART App Launch "Backend Services" OAuth2 flow (client-credentials-style, JWT client assertion).
2. Epic custom profile & extension handling — scoped to extensions on Medication/AllergyIntolerance resources (tied to the existing prescription-refill-risk-triage reference workflow, not "any Epic extension").
3. Epic proprietary quirks — bounded to exactly three: non-standard pagination/_count behavior, a non-standard required search-parameter combination, and OperationOutcome error-shape deviations.

_____________

Write up a PRD for the problem statement we agreed on so far.  Assume in the PRD, very easy ways for developers to access the Epic info (dont assume a complicated accoount setup process that you as Claude cannot do by my simple promting). Later, in the planning/design documents, those assumptions will be laid out fully, and aligned with the PRD you wtite now. Go!

### Claude response

*[Claude has not completed this turn yet.]*

<details>
<summary>Execution details — 9 tool events</summary>

### Turn 2 activity

- **AskUserQuestion** `{"questions": [{"question": "Where should epic-emulator get its FHIR data from?", "header": "Data source", "options": [{"label": "Standalone, own embedded store (Recommended)", "description": "Own Spr…`

### Turn 4 activity

- **Bash** `ls /home/vscode/.claude/projects/-workspaces-fhir-agent/memory/ && echo "---" && grep -ril "pharmacy\|PBM\|benefit\|formulary" /home/vscode/.claude/projects/-workspaces-fhir-agent/memory/ 2>/dev/null`
- **Bash** `git log --all --oneline -i --grep="pharmacy\|PBM\|benefit\|formulary" | head -50`
- **Bash** `grep -ril "pharmacy\|PBM\|formulary\|benefit" --include="*.py" --include="*.java" --include="*.md" --include="*.yaml" --include="*.yml" . 2>/dev/null | grep -v "/.git/" | head -50`
- **Read** `/home/vscode/.claude/projects/-workspaces-fhir-agent/memory/phase2-planning-state.md`
- **Bash** `echo "=== rxclaim-emulator/README.md ==="; cat rxclaim-emulator/README.md 2>/dev/null; echo; echo "=== claims-service/README.md ==="; cat claims-service/README.md 2>/dev/null; echo; echo "=== data/pay…`

### Turn 6 activity

- **Bash** `ls docs/ 2>/dev/null; echo "---phase2---"; ls docs/phase2/ 2>/dev/null; echo "---phase3---"; ls docs/phase3/ 2>/dev/null; echo "---source-prd head---"; sed -n '1,60p' docs/phase2/source-prd.md 2>/dev/…`
- **Bash** `sed -n '1,100p' docs/phase3/prd.md 2>/dev/null; echo "...wc..."; wc -l docs/phase3/prd.md docs/phase3/decisions.md docs/phase3/design.md docs/phase3/README.md 2>/dev/null`
- **Read** `/workspaces/fhir-agent/docs/phase3/prd.md`

</details>

---

## Archive metadata

- **Source:** Claude Code
- **Session ID:** `265be5b6-c550-4af6-bed7-7be2bca6b9c4`
- **Created:** 31 July 2026, 12:31 UTC
- **Last updated:** 31 July 2026, 17:46 UTC
- **Turns:** 6
- **Status:** Incomplete
